본문 바로가기
KERD
논문KCI 등재

MANAGEMENT OF HASĀH WA RAML AL-KULYA (NEPHROLITHIASIS) IN UNANI SYSTEM OF MEDICINE: A REVIEW

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류의학일반

초록

The kidneys are exposed to toxicants and waste product and can be affected easily by these toxicants and by products of the metabolism. The consumption of adequate water is necessary to remove waste and to keep kidney healthy. Deficiency of liquid in the blood leads to various adverse effects on the kidney. The most common adverse deficiency of liquid in blood is deposition of solid matter in the kidney and subsequently formation of kidney stone. Nephrolithiasis (kidney stone) can be treated by drugs if it is small in size but if it blocks the route due to its big size then surgery is the only way to remove it. The recurrence rate of the problem is very high and it may reappear within 10 years. In Unani literature Hasāh wa Raml al-Kulya (nephrolithiasis) is described in detail. As per Unani literature stagnation of Ghalīz mādda (filthy and viscous matter) in the kidney is the main cause of the formation of kidney stone. Various single and compound formulations drugs are described for the management of kidney stone which are very effective as well as safe. Management is divided into two parts i.e. symptomatic treatment to relieve pain and to methods adopted to remove stone from the kidney. Musakkin-i-Waja‘(analgesic) drugs are used for pain while Mufattit-i-Hasāh (lithotriptic) and Mudirr-i-Bawl (Diuretic) drugs are used to remove stone. Majoon Aqrab, Qurs Kaknaj and Dawa-e-Gurda etc. are compound drugs mentioned in literature for removal of kidney stone. Single drugs like Alu Balu, Tukhm Khayar, and Kharkhask etc. are also used for same purpose.

Abstract

The kidneys are exposed to toxicants and waste product and can be affected easily by these toxicants and by products of the metabolism. The consumption of adequate water is necessary to remove waste and to keep kidney healthy. Deficiency of liquid in the blood leads to various adverse effects on the kidney. The most common adverse deficiency of liquid in blood is deposition of solid matter in the kidney and subsequently formation of kidney stone. Nephrolithiasis (kidney stone) can be treated by drugs if it is small in size but if it blocks the route due to its big size then surgery is the only way to remove it. The recurrence rate of the problem is very high and it may reappear within 10 years. In Unani literature Hasāh wa Raml al-Kulya (nephrolithiasis) is described in detail. As per Unani literature stagnation of Ghalīz mādda (filthy and viscous matter) in the kidney is the main cause of the formation of kidney stone. Various single and compound formulations drugs are described for the management of kidney stone which are very effective as well as safe. Management is divided into two parts i.e. symptomatic treatment to relieve pain and to methods adopted to remove stone from the kidney. Musakkin-i-Waja‘(analgesic) drugs are used for pain while Mufattit-i-Hasāh (lithotriptic) and Mudirr-i-Bawl (Diuretic) drugs are used to remove stone. Majoon Aqrab, Qurs Kaknaj and Dawa-e-Gurda etc. are compound drugs mentioned in literature for removal of kidney stone. Single drugs like Alu Balu, Tukhm Khayar, and Kharkhask etc. are also used for same purpose.

참고문헌 (22)

  1. "American kidney funds: fighting on all fronts"[URL]
  2. Anonymous, "National Formulary of Unani Medicine, Part-I" (2006), CCRUM, Department of AYUSH, Ministry of Health & Family Welfare
  3. Anonymous, "National Formulary of Unani Medicine, Part-II, Vol-I" (2007), Department of AYUSH, Ministry of Health & Family Welfare
  4. Anonymous, "National Formulary of Unani Medicine, Part-IV" (2006), Department of AYUSH, Ministry of Health & Family Welfare
  5. Anonymous, "National Formulary of Unani Medicine, Part-VI" (2011), Department of AYUSH, Ministry of Health & Family Welfare
  6. "National Kidney Foundation"[URL]
  7. Anonymous, "Standard Unani Medical Terminology" (2012), Central Council for Research in Unani Medicine, Ministry of AYUSH
  8. Arzani MA, "Meezan al-Tib" (1992), National Council for promotion of Urdu language
  9. Arzānī MA, "Tibb-e-Akbar Urdu" (1924), Faisal Publisher
  10. Cheungpasitporn W, "The risk of kidney cancer in patients with kidney stones: A systematic review and meta\_analysis", QJM, 108, pp.205~212 (2015)
  11. Ghani N, "Khazainul Advia" (2011), Idara Kitabul Shifa
  12. Ibn Sīnā, "al-Shaykh al-Ra’īs Abū ‘Alī al-Husayn ibn ‘Abd Allāh", Al-Qānūn fi’l Tibb, Idara Kitabul Shifa
  13. Kabir al-Din, "Ilmul AdviyaNafisi" (2007), Aijaz Publishing House
  14. Kabir al-Din, "Kitabul Advia, Vol-II, Makhzanul Mufradat, Daftraul Masih" (1955)
  15. Khan Ajmal, "Haziq", pp.275~278 (1987), Hindustani Dawakhana Delhi
  16. Lieske JC, "Renal stone epidemiology in Rochester, Minnesota: An update", Kidney Int, 69, pp.760~764 (2006)
  17. Long LO, "Update on nephrolithiasis management", Minerva Urol Nefrol, 59, pp.317~325 (2007)
  18. López M, "History, epidemiology and regional diversities of urolithiasis", Pediatr Nephrol, 25, pp.49~59 (2010)
  19. Nafis ibn, "Sharh al-Asbab wa’l ‘Alamat, Vol. III-IV", pp.305~309, Aijaz Publishing House
  20. Rule AD, "The ROKS nomogram for predicting a second symptomatic stone episode", J Am Soc Nephrol, 25, pp.2878~2886 (2014)
  21. Shah J, "Urolithiasis through the ages", BJU Int, 89, pp.801~889 (2002)
  22. Sofia NH, "Prevalence and Risk Factors of Kidney Stone", Global Journal for Research Analysis, 5(3), pp.183~187 (2016)

관련 논문AI추천

이 간행물의 다른 논문 (7건)